Aids In India

This paper revolves around the Public health related aspects of industrial and intellectual property rights policies in a developing country with respect to Aids in India. It also focusses on its preventive measures, status of the epidemic with referance to the Indian Specificities, measures of Public health, availability and knowledge of condoms, NACO's effort to spread awareness and the ARV production in India with main players as in Cipla and Ranbaxy. [CSH OP NO 8]

MoreLess

Year of publication:	2009-05
Authors:	Guennif, Samira
Institutions:	eSocialSciences
Subject:	NACO \| HIV \| Asia \| Northern multinational companies \| anti-AIDS treatments \| anti-retroviral drugs \| Glaxo-Smith-Kline \| Bristol-Myers Squibb \| Boerhinger- Ingelheim \| National AIDS Committee \| National AIDS Control Program \| sexually transmitted diseases \| antenatal clinics \| World Bank Model \| epidemic \| high-risk sexual behaviour \| prostitution \| public awareness \| prevention \| blood collection system \| NACO objective \| ARV \| Ranbaxy \| Cipla \| condoms

More details

Series:	Working Papers.
Type of publication:	Book / Working Paper
Language:	English
Notes:	Institutional Papers
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10004972723